AtriCure Company Insiders

AtriCure employs about 1.3 K people. The company is managed by 13 executives with a total tenure of roughly 35 years, averaging almost 2.0 years of service per executive, having 100.0 employees per reported executive. Evaluation of AtriCure's management performance can provide insight into the firm performance.
Michael Carrel  CEO
CEO and President and Director
Justin Noznesky  President
Senior Vice President Marketing and Business Development
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

AtriCure Management Team Effectiveness

The company has return on total asset (ROA) of (0.0265) % which means that it has lost $0.0265 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0611) %, meaning that it created substantial loss on money invested by shareholders. AtriCure's management efficiency ratios could be used to measure how well AtriCure manages its routine affairs as well as how well it operates its assets and liabilities.
AtriCure holds a total of 49.72 Million outstanding shares. The majority of AtriCure outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AtriCure to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AtriCure. Please pay attention to any change in the institutional holdings of AtriCure as this could imply that something significant has changed or is about to change at the company. Also note that nearly one million four hundred eighty-one thousand five hundred sixty-six invesors are currently shorting AtriCure expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as AtriCure in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of AtriCure, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

AtriCure Workforce Comparison

AtriCure is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 45,721. AtriCure holds roughly 1,300 in number of employees claiming about 2.84% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

AtriCure Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AtriCure insiders, such as employees or executives, is commonly permitted as long as it does not rely on AtriCure's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, AtriCure insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

AtriCure Notable Stakeholders

An AtriCure stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AtriCure often face trade-offs trying to please all of them. AtriCure's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AtriCure's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael CarrelCEO and President and DirectorProfile
Justin NozneskySenior Vice President Marketing and Business DevelopmentProfile
Deborah YountChief OfficerProfile
Tonya SPHRVP HRProfile
Vinayak DoraiswamyChief OfficerProfile
JD CCEPChief OfficerProfile
Salvatore JDChief OfficerProfile
CCEP CCEPChief OfficerProfile
Douglas SeithChief OfficerProfile
Valerie StorchWillhausVice CommunicationsProfile
Angela WirickChief OfficerProfile
Amalio MDEx OfficerProfile
Angela CPAChief OfficerProfile
String symbol = request.getParameter("s");

AtriCure Workforce Analysis

Traditionally, organizations such as AtriCure use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AtriCure within its industry.

AtriCure Manpower Efficiency

Return on AtriCure Manpower

Revenue Per Employee357.9K
Revenue Per Executive35.8M
Net Loss Per Employee34.4K
Net Loss Per Executive3.4M
Working Capital Per Employee149.5K
Working Capital Per Executive15M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Tools for AtriCure Stock

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing